DRIO (DarioHealth Corp. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by DRIO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-28 | Dennis Matheis | Director | MIXED | — | — |
| 2025-09-15 | DENNIS M MCGRATH | Director | A | — | — |
| 2025-09-15 | Hila Karah | Director | A | — | — |
| 2025-09-15 | Dennis Matheis | Director | A | — | — |
| 2025-09-15 | Yoav Shaked | Director | A | — | — |
| 2025-09-15 | Steven Charles Nelson | President and CCO | A | — | — |
| 2025-09-15 | Chen Franco-Yehuda | Chief Financial Officer | A | — | — |
| 2025-09-15 | ADAM K STERN | Director | A | — | — |
| 2025-09-15 | Lawrence B. Leisure | Director | A | — | — |
| 2025-09-15 | Erez Raphael | Chief Executive Officer | A | — | — |
| 2025-08-27 | Steven Charles Nelson | President and CCO | Buy | — | — |
| 2025-05-15 | Chen Franco-Yehuda | Chief Financial Officer | A | — | — |
| 2025-02-25 | JON H. KAPLAN | Director | A | — | — |
| 2025-01-10 | ADAM K STERN | Director | Buy | — | — |
| 2024-11-14 | Steven Charles Nelson | Chief Commercial Officer | Buy | — | — |
| 2024-09-12 | Steven Charles Nelson | Chief Commercial Officer | Buy | — | — |
| 2024-09-10 | Steven Charles Nelson | Chief Commercial Officer | Buy | — | — |
| 2024-08-28 | Erez Raphael | Chief Executive Officer | Buy | — | — |
| 2024-08-23 | Steven Charles Nelson | Chief Commercial Officer | Buy | — | — |
| 2024-08-23 | Erez Raphael | Chief Executive Officer | Buy | — | — |
| 2024-08-20 | Erez Raphael | Chief Executive Officer | Buy | — | — |
| 2024-08-20 | Steven Charles Nelson | Chief Commercial Officer | Buy | — | — |
| 2024-06-07 | Steven Charles Nelson | Chief Commercial Officer | A | — | — |
| 2024-03-08 | Dennis Matheis | Director | A | — | — |
| 2024-03-08 | Hila Karah | Director | A | — | — |
| 2024-03-08 | Zvi Ben-David | Chief Financial Officer | A | — | — |
| 2024-03-08 | Yoav Shaked | Director | A | — | — |
| 2024-03-08 | Erez Raphael | Chief Executive Officer | A | — | — |
| 2024-03-08 | JON H. KAPLAN | Director | A | — | — |
| 2024-03-08 | ADAM K STERN | Director | A | — | — |
| 2024-03-08 | RICHARD ALAN ANDERSON | President | A | — | — |
| 2024-03-08 | DENNIS M MCGRATH | Director | A | — | — |
| 2024-03-01 | ADAM K STERN | Director | A | — | — |
| 2024-02-21 | Tomer Ben-Kiki | Chief Operating Officer | A | — | — |
| 2023-05-08 | Erez Raphael | Chief Executive Officer | Buy | — | — |
| 2023-05-08 | JON H. KAPLAN | Director | Buy | — | — |
| 2023-05-08 | Dennis Matheis | Director | Buy | — | — |
| 2023-05-08 | Yoav Shaked | Director | Buy | — | — |
| 2023-01-18 | Erez Raphael | Chief Executive Officer | Sell | — | — |
| 2022-12-23 | DENNIS M MCGRATH | Director | Sell | — | — |
| 2022-06-10 | RICHARD ALAN ANDERSON | President, GM of North America | D | — | — |
| 2022-05-20 | DENNIS M MCGRATH | Director | A | — | — |
| 2022-05-20 | Zvi Ben-David | Chief Financial Officer | A | — | — |
| 2022-05-20 | Dennis Matheis | Director | A | — | — |
| 2022-05-20 | Dror Bacher | Chief Operating Officer | A | — | — |
| 2022-05-20 | Hila Karah | Director | A | — | — |
| 2022-05-20 | ADAM K STERN | Director | A | — | — |
| 2022-05-20 | Erez Raphael | Chief Executive Officer | A | — | — |
| 2022-05-20 | RICHARD ALLAN ANDERSON | President, GM of North America | A | — | — |
| 2022-05-20 | Yoav Shaked | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 158,747 | — |
| — | Chief Financial Officer | 37,391 | — |
| — | Director | 35,863 | — |
| — | President and CCO | 34,750 | — |
| — | Director | 32,900 | — |
| — | Director | 32,894 | — |
| — | Director | 30,965 | — |
| — | Chief Financial Officer | 30,000 | — |
| — | Director | 28,596 | — |
| — | Director | 27,737 | — |
| — | GM MSK | 21,538 | — |
| — | Chief Operating Officer | 13,296 | — |
| — | Director | 5,579 | — |
| — | President | 5,444 | — |
| — | Director | 2,743 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DRIO quote page; the site-wide leaderboard is on the insider transactions hub.